Webhas the potential to improve patient outcomes. Decision aids are an effective way for both patients and caregivers to conduct joint decision-making at the point of treatment (Ye et al., 2024). Statin Choice Decision Aid The SCDA is designed to determine the patient’s 10-year ASCVD risk score and WebNov 10, 2024 · Statin use among patients with atherosclerotic cardiovascular disease remains suboptimal because of various patient‐ and clinician‐related factors. The development of a decision aid to facilitate discussion of SASEs, clinician decision‐making, and SASE management may improve statin use in this high‐risk population.
Are statins the best choice for me? - National Institute for …
WebSetting and participants: Twenty-two patients with diabetes (57% of them on statins) and six endocrinologists working in a referral diabetes clinic randomly assigned to use the decision aid during the consultation. Main outcome measures: Proportion and nature of unintended use of the Statin Choice decision aid. WebThis decision aid is intended to help patients in whom treatment with a statin is being considered, for primary or secondary prevention of cardiovascular disease (CVD). Primary prevention means they have never had a stroke or heart attack and Secondary Prevention means they have. Whether you decide to take a statin or not we always advice birth control generic brand
Taking a statin to reduce the risk of coronary ... - NICE
WebAbstract. Objective: To assess the impact of a decision aid on perceived risk of heart attacks and medication adherence among urban primary care patients with diabetes. Methods: We randomly allocated 150 patients with diabetes to participate in a usual primary care visit either with or without the Statin Choice tool. WebThe Statin Choice 1-page decision aid included the patient's name, cardiovascular risk factors, and 1 of 3 levels of baseline 10-year cardiovascular risk: 10% for patients with 10-year cardiovascular risk less than 15%, 7 20% for patients with estimated risk between 15% and 30%, and 50% for patients with estimated risk greater than 30%. WebStatins should be used with caution in patients at increased risk of muscle toxicity, such as the elderly, those with a personal or family history of muscular disorders, history of muscular toxicity or unexplained persistent muscle pain, history of liver disease, a high alcohol intake, known genetic polymorphisms—consult product literature, renal … birth control guide fda